- Title
- A 6-month, multicenter, open-label study of fixed dose naproxen/esomeprazole in adolescent patients with juvenile idiopathic arthritis
- Creators
- Daniel J. Lovell - Cincinnati Children's Hospital Medical CenterJason A. Dare - Arkansas Children's HospitalMegan Francis-Sedlak - Horizon Therapeutics (United States)Julie Ball - Horizon Therapeutics (United States)Brian D. LaMoreaux - Horizon Therapeutics (United States)Emily Von Scheven - University of California, San FranciscoAdam Reinhardt - Children's Hospital & Medical CenterRita Jerath - Augusta University HealthOral Alpan - O&O Alpan (United States)Ramesh Gupta - Rheumatology and Immunology Private Practice, 6005 Park Ave, Suite 409, Memphis, TN 38119 USADonald Goldsmith - St. Christopher's Hospital for ChildrenAndrew Zeft - Cleveland ClinicHenry Naddaf - Toledo Clinic Cancer CenterBeth Gottlieb - Cohen Children's Medical CenterLawrence Jung - Children's NationalRobert J. Holt - Horizon Therapeutics (United States)
- Publication Details
- Pediatric rheumatology online journal, v 16(1), pp 41-41
- Publisher
- BioMed Central
- Grant note
- None / ;
- Resource Type
- Journal article
- Language
- English
- Academic Unit
- Pediatrics
- Web of Science ID
- WOS:000436637000001
- Scopus ID
- 2-s2.0-85049091401
- Other Identifier
- 991021838612504721
Journal article
A 6-month, multicenter, open-label study of fixed dose naproxen/esomeprazole in adolescent patients with juvenile idiopathic arthritis
Pediatric rheumatology online journal, v 16(1), pp 41-41
26 Jun 2018
PMID: 29941047
Featured in Collection : UN Sustainable Development Goals @ Drexel
Metrics
Details
UN Sustainable Development Goals (SDGs)
This publication has contributed to the advancement of the following goals:
InCites Highlights
Data related to this publication, from InCites Benchmarking & Analytics tool:
- Collaboration types
- Domestic collaboration
- Web of Science research areas
- Pediatrics
- Rheumatology